Ken Griffin's position in Esperion Therapeutics is currently worth $1.57 Million. That's 0.00% of their equity portfolio (2491st largest holding). The first Esperion Therapeutics trade was made in Q1 2015. Since then Ken Griffin bought shares 57 more times and sold shares on 44 occasions. The investor's estimated purchase price is $17 Million, resulting in a loss of 91%.